BIOFARM
96 articole · RSS
Biofarm Reports RON70.9M Net Profit For 2022, Up 18% YoY
Drug manufacturer Biofarm (BIO.RO) on Monday (Feb 27) reported a turnover of RON277 million for 2022, up 16% from 2021, and a net profit of RON70.9 million, up 18% on the year.
Biofarm Posts 20% Higher Net Profit and 17% Higher Sales in Jan-Sep
Drug manufacturer Biofarm (BIO.RO) recorded a net profit of RON65.7 million in the first nine months of 2022, an increase of 20% on the previous year, according to ZF calculations based on d...
Biofarm Invests EUR44M In Its New Production Unit Inaugurated In Bucharest In 2021
Pharmaceutical manufacturer Biofarm (BIO.RO) has reached total investments of over EUR44 million in its new plant inaugurated in capital Bucharest in 2021, which is the largest greenfield in...
Biofarm Seeks 16% Growth in Revenue and 10% Higher Profit in 2022
Pharmaceutical manufacturer Biofarm (BIO.RO) expects 16% higher revenue compared with RON239 million of 2021, as well as 15% higher EBITDA from about RON82 million last year.
Biofarm Aims to Double Turnover in 5-7 Years
Romanian drug maker Biofarm, a major player on the local market, plans to double turnover within the next 5-7 years after having opened a new drug plant in Bucharest last year in the wake of...
Biofarm Sales Up 10% To RON239M, Net Profit Up 11% To RON60M YoY In 2021
Romanian pharmaceutical products manufacturer Biofarm (BIO.RO) on Monday said it ended 2021 with a turnover of RON239 million, up 10% on the year, and a net profit of RON60 million, up 11% f...
Biofarm Bets on New Internally-Developed Products
Romanian-held pharmaceutical products manufacturer Biofarm, the fifth largest player on this market by turnover, plans to add internally-developed products to its portfolio, especially as th...
Biofarm Inaugurates Second Drug Plant In Bucharest In Over EUR35M Investment
Pharmaceutical manufacturer Biofarm (BIO.RO) has inaugurated a new pharmaceutical manufacturing and testing facility in capital Bucharest, which entailed an investment of over EUR35 million.
Biofarm Sees 8% Turnover Growth, 15% Profit Increase In 2017-2020 Period
Romanian pharmaceutical company Biofarm Bucuresti (BIO.RO) on Wednesday said it registered an aggregate growth of 8% in turnover and of 15% in profit during 2017 – 2020 period.